Skip to main navigation Skip to search Skip to main content

Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus

  • Andrea J. Parsons
  • , Sabrina I. Ophir
  • , Thomas J. Gardner
  • , Jailene Casado Paredes
  • , Kathryn R. Stein
  • , Steven M. Kwasny
  • , Steven C. Cardinale
  • , Matthew Torhan
  • , Mark N. Prichard
  • , Scott H. James
  • , Kristina E. Atanasoff
  • , Narendran G-Dayanandan
  • , Terry L. Bowlin
  • , Timothy J. Opperman
  • , Domenico Tortorella

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science